Mantle Cell Lymphoma: Understanding the Ferocity of Relapse

Tycel J. Phillips, MD

January 12, 2023

Tycel J. Phillips, MD, comments on the distinctive speed and aggression that often characterize the course of mantle cell lymphoma.

Only by bringing the full range of treatment options to bear in a timely fashion, Dr Phillips asserts, can clinicians hope to confront the variable directions of this disease and provide the most effective treatment for patients in a relapsed/refractory setting.

Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.

Cite this: Mantle Cell Lymphoma: Understanding the Ferocity of Relapse - Medscape - Jan 12, 2023.

Comments

Commenting is limited to medical professionals. To comment please Log-in.

Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.

processing....

Mantle Cell Lymphoma: Understanding the Ferocity of Relapse

Tables

Authors and Disclosures

Authors and Disclosures

Expert

Tycel J. Phillips, MD

Comments

Email This

Feedback